Gene · 862
Papers4,591
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 4,591
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The dual role of autophagy in acute myeloid leukemia. | J Hematol Oncol | 2022 | 35526025 | PubTator, text mining | PubMed |
| The Nuclear Proteins TP73 and CUL4A Confer Resistance to Cytarabine by Induction of Translesion DNA Synthesis via Mono-ubiquitination of PCNA. | Hemasphere | 2022 | 35519003 | PubTator, text mining | PubMed |
| Inhibition of pyrimidine biosynthesis targets protein translation in acute myeloid leukemia. | EMBO Mol Med | 2022 | 35514210 | PubTator, text mining | PubMed |
| Flow cytometry, molecular analysis, and other special techniques (in Serous Fluid Cytopathology). | Cytojournal | 2022 | 35510118 | PubTator, text mining | PubMed |
| Images from the Haematologica Atlas of Hematologic Cytology: acute myeloid leukemia with t(8;21)(q22;q22.1); RUNX1-RUNX1T1. | Haematologica | 2022 | 35502592 | PubTator, text mining | PubMed |
| Circulating lnc-LOC as a novel noninvasive biomarker in the treatment surveillance of acute promyelocytic leukaemia. | BMC Cancer | 2022 | 35501730 | PubTator, text mining | PubMed |
| Genetic and Epigenetic Signatures in Acute Promyelocytic Leukemia Treatment and Molecular Remission. | Front Genet | 2022 | 35495123 | PubTator, text mining | PubMed |
| The Histone Deacetylase Inhibitor I13 Induces Differentiation of M2, M3 and M5 Subtypes of Acute Myeloid Leukemia Cells and Leukemic Stem-Like Cells. | Front Oncol | 2022 | 35494054 | PubTator, text mining | PubMed |
| TIM-3 Expression Level on AML Blasts Correlates With Presence of Core Binding Factor Translocations Rather Than Clinical Outcomes. | Front Oncol | 2022 | 35494006 | PubTator, text mining | PubMed |
| Increased expression of RUNX3 inhibits normal human myeloid development. | Leukemia | 2022 | 35490198 | PubTator, text mining | PubMed |
| Detection of residual and chemoresistant leukemic cells in an immune-competent mouse model of acute myeloid leukemia: Potential for unravelling their interactions with immunity. | PLoS One | 2022 | 35486629 | PubTator, text mining | PubMed |
| Clinical characteristics, treatment, and prognosis of 118 cases of myeloid sarcoma. | Sci Rep | 2022 | 35474239 | PubTator, text mining | PubMed |
| Saprochete capitata: Emerging Infections from Uncommon Microorganisms in Hematological Diseases. | Hematol Rep | 2022 | 35466175 | PubTator, text mining | PubMed |
| Technical Validation and Clinical Utility of an NGS Targeted Panel to Improve Molecular Characterization of Pediatric Acute Leukemia. | Front Mol Biosci | 2022 | 35463953 | PubTator, text mining | PubMed |
| Natural Bioactive Compounds Targeting Histone Deacetylases in Human Cancers: Recent Updates. | Molecules | 2022 | 35458763 | PubTator, text mining | PubMed |
| Chromosome Territories in Hematological Malignancies. | Cells | 2022 | 35456046 | PubTator, text mining | PubMed |
| Lessons Learned from Donor Cell-Derived Myeloid Neoplasms: Report of Three Cases and Review of the Literature. | Life (Basel) | 2022 | 35455050 | PubTator, text mining | PubMed |
| Next-Generation DNA Sequencing-Based Gene Panel for Diagnosis and Genetic Risk Stratification in Onco-Hematology. | Cancers (Basel) | 2022 | 35454892 | PubTator, text mining | PubMed |
Evaluating Established Roles, Future Perspectives and Methodological Heterogeneity for Wilms' Tumor 1 (WT1) Antigen Detection in Adult Renal Cell Carcinoma, Using a Novel N-Terminus Targeted Antibody (Clone WT49). | Biomedicines | 2022 | 35453662 | PubTator, text mining | PubMed |
| In vivo temporal resolution of acute promyelocytic leukemia progression reveals a role of Klf4 in suppressing early leukemic transformation. | Genes Dev | 2022 | 35450883 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/862/papers?page=38